| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0064 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |